{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:21:00Z","timestamp":1793942460274,"version":"4.8.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1001\/jamaoncol.2022.0514","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T15:04:26Z","timestamp":1652367866000},"page":"1047","source":"Crossref","is-referenced-by-count":24,"title":["Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases"],"prefix":"10.1001","volume":"8","author":[{"given":"Debu","family":"Tripathy","sequence":"first","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Tolaney","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Seidman","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey K.","family":"Anders","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuhad","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Twelves","sequence":"additional","affiliation":[{"name":"University of Leeds and Leeds Teaching Hospitals Trust, Leeds, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Di\u00e9ras","sequence":"additional","affiliation":[{"name":"Centre Eug\u00e8ne Marquis, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Du","sequence":"additional","affiliation":[{"name":"Nektar Therapeutics, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue L.","family":"Currie","sequence":"additional","affiliation":[{"name":"Nektar Therapeutics, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Hoch","sequence":"additional","affiliation":[{"name":"Nektar Therapeutics, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"Nektar Therapeutics, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Hannah","sequence":"additional","affiliation":[{"name":"Nektar Therapeutics, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cort\u00e9s","sequence":"additional","affiliation":[{"name":"International Breast Cancer Center, Quironsalud Group, Barcelona, Spain"},{"name":"Vall d\u2019Hebron Institute of Oncology, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ATTAIN Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Tsoi","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Chua","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elgene","family":"Lim","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Underhill","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Clingan","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Chan","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Deleu","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Borms","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois P.","family":"Duhoux","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Awada","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pascale","family":"Graas","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Canon","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Papadimitriou","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Velu","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Trudeau","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thirlwell","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Barthelemy","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miruna","family":"Timar David","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Loirat","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Mousseau","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Thery","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Fehm","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Tokar","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgeta","family":"Fried","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Wolf","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gianni","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelino","family":"De Laurentiis","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cognetti","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Orditura","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Bengala","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Vieira","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Teixeira","family":"de Sousa","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Fatima","family":"Cabral da Rocha Cardoso","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Cruz Jurado","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Angel","family":"Garcia-Saenz","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gomez","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ruiz-Borrego","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"De La Cruz-Merino","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Perez Garcia","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"S\u00e1nchez-Rovira","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Ortega","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fern\u00e1ndez Abad","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Madhusudan","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Armstrong","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavani","family":"Chalasani","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Schwartzberg","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Khagi","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Potter","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Perez","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Williams","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Melisko","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Harris","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foluso","family":"Ademuyiwa","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Specht","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DiSean","family":"Kendall","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Young","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Nikolinakos","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine H.R.","family":"Tkaczuk","sequence":"additional","affiliation":[{"name":"for the ATTAIN Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"cbr220007r1","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.clbc.2019.06.007","article-title":"Incidence of brain metastases in nonmetastatic and metastatic breast cancer: is there a role for screening?","volume":"20","author":"Komorowski","year":"2020","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"cbr220007r3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00280-014-2577-7","article-title":"Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models.","volume":"74","author":"Hoch","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"15","key":"cbr220007r4","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/S1470-2045(15)00332-0","article-title":"Etirinotecan pegol (NKTR-102) versus treatment of physician\u2019s choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.","volume":"16","author":"Perez","year":"2015","journal-title":"Lancet Oncol"},{"issue":"2","key":"cbr220007r5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-017-4304-7","article-title":"Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.","volume":"165","author":"Cort\u00e9s","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"cbr220007r6","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2217\/fon-2019-0180","article-title":"ATTAIN: phase III study of etirinotecan pegol versus treatment of physician\u2019s choice in patients with metastatic breast cancer and brain metastases.","volume":"15","author":"Tripathy","year":"2019","journal-title":"Future Oncol"},{"issue":"6","key":"cbr220007r7","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group.","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"issue":"20","key":"cbr220007r8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1200\/JCO.2014.58.8517","article-title":"Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases.","volume":"33","author":"Subbiah","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"cbr220007r9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13058-015-0665-1","article-title":"Breast cancer brain metastases: biology and new clinical perspectives.","volume":"18","author":"Witzel","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"7","key":"cbr220007r10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJMoa1914609","article-title":"Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer.","volume":"382","author":"Murthy","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"cbr220007r11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/annonc\/mdu486","article-title":"Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.","volume":"26","author":"Krop","year":"2015","journal-title":"Ann Oncol"},{"key":"cbr220007r12","doi-asserted-by":"publisher","first-page":"PD13","DOI":"10.1158\/1538-7445.SABCS20-PD13-07","article-title":"Subgroup analysis of patients with brain metastases from the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in metastatic triple-negative breast cancer.","volume":"81","author":"Di\u00e9ras","year":"2021","journal-title":"Cancer Res"},{"issue":"10","key":"cbr220007r13","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.annonc.2020.06.020","article-title":"Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial.","volume":"31","author":"Montemurro","year":"2020","journal-title":"Ann Oncol"},{"key":"cbr220007r14","doi-asserted-by":"publisher","first-page":"S1287","DOI":"10.1016\/j.annonc.2021.08.2087","article-title":"Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (Pts) with HER2+ metastatic breast cancer (mBC): results of the randomized phase III DESTINY-Breast03 study.","volume":"32","author":"Cort\u00e9s","year":"2021","journal-title":"Ann Oncol"},{"key":"cbr220007r15","doi-asserted-by":"publisher","first-page":"S486","DOI":"10.1016\/j.annonc.2021.08.563","article-title":"Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: results from the first stage of the phase II TUXEDO-1 trial.","volume":"32","author":"Bartsch","year":"2021","journal-title":"Ann Oncol"},{"key":"cbr220007r2","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: central nervous system cancers (version 2.2001). Accessed September 1, 2021. https:\/\/www.nccn.org\/guidelines\/guidelines-detail"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2792237\/jamaoncology_tripathy_2022_br_220007_1658255490.2946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T15:02:25Z","timestamp":1658415745000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2792237"}},"subtitle":["Final Results From the Phase 3 ATTAIN Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2022.0514","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}